Rakesh Gandhi of FRR Shares is bullish on Ranbaxy Laboratories and recommended to buy around Rs 450 with a stop loss of Rs 430 and short-term target of Rs 470.
first published: May 15, 2013 09:14 am
A collection of the most-viewed Moneycontrol videos.

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live

Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live

Small-Caps & Risk: What Investors Often Miss

Nifty’s Best Case Target & Top Stock Bets For 2026| IPO Wave Set To Get Bigger| Opening Bell Live
You are already a Moneycontrol Pro user.

